Advertisement

New York Gov. Cuomo joins union fight to preserve ACA

By Jonathan LaMantia, Crain's New York Business  |  February 22, 2017

At a rally in Bronx, N.Y., Wednesday, Gov. Andrew Cuomo defended the Affordable Care Act and warned that Washington, D.C., is abandoning the middle class.

Piedmont taking over 27 Walgreens clinics in Atlanta

Piedmont taking over 27 Walgreens clinics in Atlanta

By Dave Barkholz  |  February 22, 2017

Piedmont Healthcare has agreed to take over and operate 27 Walgreens in-store clinics in the Atlanta metropolitan area. Piedmont joins systems in other states which have bought or leased retail clinics meant to provide fast, convenient care for patients with minor ailments.

Epic's new app program tries to connect EHR networks

Epic's new app program tries to connect EHR networks

By Joseph Conn  |  February 22, 2017

Epic Systems is trying to get providers' electronic health record systems connected through a new app program that uses Fast Healthcare Interoperability Resources, or FHIR.

65,000 providers have been cut from state Medicaid rolls

65,000 providers have been cut from state Medicaid rolls

By Virgil Dickson  |  February 22, 2017

A provision of the Affordable Care Act that requires providers to revalidate or recertify their Medicaid reimbursement eligibility has caused 65,000 providers to be stripped from the federal program, according to a Modern Healthcare analysis.

Northwestern University professor is on his fourth health venture

By Howard Wolinsky, Crain's Chicago Business  |  February 22, 2017

Thomas Meade, serial entrepreneur, is on to his fourth venture,​ Ohmx, a 20-employee company in Evanston, Illinois, that​ is developing electronic handheld devices to detect proteins such as those generated from heart attacks

News from other sources ...

By Modern Healthcare  |  February 22, 2017

Today's roundup of technology, pharmaceutical and device news includes Gilead Sciences paying $125 million to Sarepta Therapeutics for a priority review voucher, a new patient advocacy group focused on drug prices launching, and more.

Advertisement